Operating Lease, Right-of-Use Asset of Apogee Therapeutics, Inc. from 31 Dec 2023 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Apogee Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2023 to 30 Sep 2025.
  • Apogee Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $9,646,000, a 20% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Apogee Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $9,646,000 -$2,480,000 -20% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $10,586,000 +$6,359,000 +150% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $11,507,000 +$9,556,000 +490% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $11,365,000 +$9,148,000 +413% 31 Dec 2024 10-Q 10 Nov 2025 2025 Q3
Q3 2024 $12,126,000 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $4,227,000 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 $1,951,000 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 $2,217,000 31 Dec 2023 10-K 03 Mar 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.